ProPhase Labs, Inc. — Director's Dealing 2022

Oct 18, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ProPhase Labs, Inc. (PRPH)
CIK: 0000868278
Period of Report: 2022-10-16

Reporting Person: Karkus Ted William (Director, CEO & CHAIRMAN, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-10-16	Common Stock, par value $0.005	M	600000	$0.6	Acquired	3388609	Direct
2022-10-16	Common Stock, par value $0.005	F	317291	$10.41	Disposed	3071318	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-10-16	Option (right to buy)	$0.6	M	600000	Disposed	2023-02-22	Common Stock (600000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock, par value $0.005	100000	Indirect

Footnotes

F1: On October 16, 2022, the Reporting Person acquired net 282,709 shares of common stock upon the exercise of stock options to purchase 600,000 shares of common stock, less 317,291 shares of common stock withheld to cover the exercise price and applicable taxes.

F2: The option vested in 35 equal monthly installments of 63,888 shares on the 1st day of each month beginning on March 1, 2018 (the "Initial Vesting Date"), and one monthly installment of 63,920 shares on the 1st day of the 36th month following the Initial Vesting Date, as described in a stock option award agreement by and between the Issuer and the Reporting Person, dated as of February 19, 2018.